Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Date

September 15, 2026-September 16, 2026

Register Now: C-Path’s 2026 Global Impact Conference

C-Path's flagship event is set to return to downtown Washington, D.C. this September 15-16 at the...

September 3, 2026

C-Path Mourns the Passing of Board Member Peter Barton Hutt

TUCSON, Ariz., September 3, 2026 — Critical Path Institute® (C-Path) is deeply saddened to announce the passing of Peter...

September 3, 2026

Advancing Neuromuscular Drug Development Through Patient-Centered Collaboration and Data Integration

The newest episode of the Critical Path Institute Podcast explores the essential collaboration between patients...

August 27, 2026

From One to Millions: Julia Vitarello on a New Vision for Individualized Medicine

"I'm very, very determined to play a role together with everyone at C-Path and others to try to make sure that the millions of...

August 25, 2026

Critical Path for Parkinson’s Announces Milestone Publication Highlighting FDA Support for Novel Biomarker to Advance Precision Medicine Strategies

TUCSON, Ariz., August 25, 2026 — Critical Path Institute® (C-Path) today announced the publication of "Regulatory...

August 24, 2026

Building a Stronger Path to Therapies for Hereditary Spastic Paraplegia and Primary Lateral Sclerosis

For more than 20 years, the Spastic Paraplegia Foundation (SPF) has worked toward a future with better...

August 24, 2026

Successful Translational Prediction of Bedaquiline’s Phase 2a Clinical Trial Results against Tuberculosis: The Zebrafish as a New Approach Methodology

Tuberculosis remains an urgent global health crisis that requires an accelerated development of novel regimens.

August 20, 2026

C-Path Achieves Internationally Recognized Certification for Information Security Management

C-Path) today announced it has achieved certification to ISO/IEC 27001:2022, the internationally...

August 20, 2026

C-Path CEO Klaus Romero Talks One to Millions on The BioCentury Show

Critical Path Institute’s One to Millions Initiative is using individualized rare disease therapies...

August 18, 2026

C-Path Receives FDA Qualification for Rheumatoid Arthritis Fatigue Measure

TUCSON, Ariz., August 18, 2026 — Critical Path Institute’s® (C-Path) Patient-Centered Evidence Consortium today announced...

Previous12 3...135 Next